北京大学学报(医学版) ›› 2018, Vol. 50 ›› Issue (6): 1063-1069. doi: 10.19723/j.issn.1671-167X.2018.06.022
Yan-ling DING,Ning SHEN(),Qing-tao ZHOU,Bei HE,Jia-jia ZHENG,Xin-mao ZHAO
摘要:
目的: 探讨非免疫缺陷宿主念珠菌血流感染的病原学与临床特点。方法: 回顾性分析2010年1月至2016年6月北京大学第三医院收治的念珠菌血流感染患者的临床与微生物学资料,比较非免疫缺陷与HIV阴性免疫缺陷宿主的基础疾病、念珠菌定植、临床表现、病原分布和药敏试验结果,以及治疗结局等方面的差异。结果: 62例患者纳入分析,男36例,女26例,年龄16~100岁,平均年龄(66.02±17.65)岁。非免疫缺陷与HIV阴性免疫缺陷宿主分别为30例和32例。非免疫缺陷宿主中,19例(19/30,63.33%)患者发生血流感染时入住重症监护室(intensive care unit,ICU),21例(21/30,70.00%)合并糖尿病或高血糖未控制,22例(22/30,73.33%)接受有创机械通气,多于HIV阴性免疫缺陷者[分别为8/32(25.00%),13/32(40.63%),7/32(21.88%)];入院与发生念珠菌血流感染时急性生理学及慢性健康状况评分(acute physiology and chronic health evaluation Ⅱ, APACHEⅡ)分别为(19.98±5.81)分和(25.61±6.52)分,序贯器官衰竭评分(sequential organ failure assessment,SOFA)分别为(6.04±6.14)分和(12.75±8.42)分,高于HIV阴性免疫缺陷者[APACHEⅡ分别为(15.09±5.82)分和(22.15±5.98)分,SOFA分别为(2.87±2.73)分和(7.66±5.64)分];粗死亡率(21/30,70.00%)较HIV阴性免疫缺陷者升高(14/32,43.75%),上述结果差异均有统计学意义(P<0.05)。两组血培养念珠菌属均以白色念珠菌最常见,患者临床表现、念珠菌定植指数、病原学分布与药敏试验结果等均相似(P>0.05)。结论: 非免疫缺陷宿主念珠菌血流感染多发生于入住ICU、病情更加危重患者,其糖尿病或未控制高血糖、接受有创机械通气患者更为突出,预后更差;其临床表现、微生物学特点等与HIV阴性免疫缺陷患者均相似。
中图分类号:
[1] | 李光辉 . 念珠菌血症的诊断与抗真菌治疗[J]. 中国感染与化疗杂志, 2011,11(2):98-100. |
[2] |
Wisplinhoff H, Bischoff T, Tallent SM , et al. Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study[J]. Clin Infect Dis, 2004,39(3):309-317.
doi: 10.1086/421946 |
[3] |
Wang H, Xiao M, Chen SC , et al. In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 national China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study[J]. J Clin Microbiol, 2012,50(12):3952-3959.
doi: 10.1128/JCM.01130-12 pmid: 23035204 |
[4] |
Guery BP, Arendrup MC, Auzinger G , et al. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis[J]. Intensive Care Med, 2009,35(1):55-62.
doi: 10.1007/s00134-008-1339-6 pmid: 18972100 |
[5] |
Dimopoulos G, Karabinis A, Samonis G , et al. Candidemia in immunocompromised and immunocompetent critically ill patients: a prospective comparative study[J]. Eur J Clin Microbiol Infect Dis, 2007,26(6):377-384.
doi: 10.1007/s10096-007-0316-2 pmid: 17525857 |
[6] |
Giri S, Kindo AJ . A review of Candida species causing blood stream infection[J]. Indian J Med Microbiol, 2012,30(3):270-278.
doi: 10.4103/0255-0857.99484 pmid: 22885191 |
[7] |
Mikulska M, Bassetti M, Ratto S , et al. Invasive candidiasis in non-hematological patients[J]. Mediterr J Hematol Infect Dis, 2011,3(1):e2011007.
doi: 10.4084/MJHID.2011.007 pmid: 21625311 |
[8] |
Safdar A, Bannister TW, Safdar Z . The predictors of outcome in immunocompetent patients with hematogenous candidiasis[J]. Int J Infect Dis, 2004,89(3):180-186.
doi: 10.1016/j.ijid.2003.05.003 pmid: 15109594 |
[9] | Vigouroux S, Morin O, Moreau P , et al. Candidemia in patients with hematologic malignancies: analysis of 7 years’ experience in a single center[J]. Haematologica, 2006,91(5):717-718. |
[10] |
Charlson ME, Pompei P, Ales KL , et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation[J]. J Chronic Dis, 1987,40(5):373-383.
doi: 10.1016/0021-9681(87)90171-8 pmid: 3558716 |
[11] |
Marra AR, Bearman GM, Wenzel RP , et al. Comparison of severity of illness scoring systems for patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa[J]. BMC Infect Dis, 2006,17(6):132.
doi: 10.1186/1471-2334-6-132 pmid: 1563469 |
[12] |
León C, Ruiz-Santana S, Saavedra P , et al. EPCAN study group. A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization[J]. Crit Care Med, 2006,34(3):730-737.
doi: 10.1097/01.CCM.0000202208.37364.7D pmid: 16505659 |
[13] |
Posteraro B, De Pascale G, Tumbarello M , et al. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index[J]. Crit Care, 2011,15(5):R249.
doi: 10.1186/cc10507 pmid: 22018278 |
[14] |
Abe M, Kimura M, Araoka H , et al. Serum (1, 3)-beta-D-glucan is an inefficient marker of breakthrough candidemia[J]. Med Mycol, 2014,52(8):835-840.
doi: 10.1093/mmy/myu066 pmid: 25349254 |
[15] |
Singer M, Deutschman CS, Seymour CW , et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3)[J]. JAMA, 2016,315(8):801-810
doi: 10.1001/jama.2016.0287 pmid: 26903336 |
[16] |
陈佰义 . 侵袭性念珠菌病早期经验治疗的临床思维[J]. 中华内科杂志, 2014,53(11):907-909
doi: 10.3760/cma.j.issn.0578-1426.2014.11.019 |
[17] |
Sims CR, Ostrosky-Zeichner L, Rex JH . Invasive candidiasis in immunocompromised hospitalized patients[J]. Arch Med Res, 2005,36(6):660-671
doi: 10.1016/j.arcmed.2005.05.015 pmid: 16216647 |
[18] |
Tragiannidis A, Tsoulas C, Kerl K , et al. Invasive candidiasis: update on current pharmacotherapy options and future perspectives[J]. Expert Opin Pharmacother, 2013,14(11):1515-1528.
doi: 10.1517/14656566.2013.805204 pmid: 23724798 |
[19] |
Ahmad S, Khan Z . Invasive candidiasis: a review of nonculture-based laboratory diagnostic methods[J]. Indian J Med Microbiol, 2012,30(3):264-269.
doi: 10.4103/0255-0857.99482 pmid: 22885190 |
[20] |
谢剑锋, 杨毅 . 重症医学科患者念珠菌血症早期诊断的困境与思路[J]. 中华内科杂志, 2015,54(5):456-457.
doi: 10.3760/cma.j.issn.0578-1426.2015.05.016 |
[21] |
Del Bono V, Delfino E, Furfaro E , et al. Clinical performance of the (1, 3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections[J]. Clin Vaccine Immunol, 2011,18(12):2113-2117.
doi: 10.1128/CVI.05408-11 pmid: 21994353 |
[22] |
Jaijakul S, Vazquez JA, Swanson RN , et al.( 1, 3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis[J]. Clin Infect Dis, 2012,55(4):521-526.
doi: 10.1093/cid/cis456 pmid: 22573851 |
[23] |
Lewis RE . Overview of the changing epidemiology of candidemia[J]. Curr Med Res Opin, 2009,25(7):1732-1740.
doi: 10.1185/03007990902990817 pmid: 19519284 |
[24] |
Pemán J, Cantón E, Miñana JJ , et al. Changes in the epidemiology of fungaemia and fluconazole susceptibility of blood isolates during the last 10 years in Spain: results from the FUNGEMYCA study[J]. Rev Iberoam Micol, 2011,28(2):91-99.
doi: 10.1016/j.riam.2011.02.005 |
[25] |
吴吉芹, 朱利平, 区雪婷 , 等. 医院获得性念珠菌血症109例临床特点及预后分析[J]. 中华传染病杂志, 2011,29(4):206-210.
doi: 10.3760/cma.j.issn.1000-6680.2011.04.003 |
[26] |
Playford EG, Nimmo GR, Tilse M , et al. Increasing incidence of candidaemia: long-term epidemiological trends, Queensland, Australia, 1999-2008[J]. J Hosp Infect, 2010,76(1):46-51.
doi: 10.1016/j.jhin.2010.01.022 pmid: 20382444 |
[27] |
Pfaller MA, Messer SA, Moet GJ , et al. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in intensive care unit (ICU) and non-ICU settings in the SENTRY Antimicrobial surveillance program (2008-2009)[J]. Int J Antimicrob Agents, 2011,38(1):65-69.
doi: 10.1016/j.ijantimicag.2011.02.016 pmid: 21514797 |
[28] |
Marriott DJ, Playford EG, Chen S , et al. Australian candidaemia study. Determinants of mortality in non-neutropenic ICU patients with candidaemia[J]. Crit Care, 2009,13(4):R115.
doi: 10.1186/cc7964 pmid: 19594912 |
[29] |
Tumbarello M, Posteraro B, Trecarichi EM , et al. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia[J]. J Clin Microbiol, 2007,45(6):1843-1850.
doi: 10.1128/JCM.00131-07 pmid: 17460052 |
[1] | 王飞,朱翔,贺蓓,朱红,沈宁. 自发缓解的滤泡性细支气管炎伴非特异性间质性肺炎1例报道并文献复习[J]. 北京大学学报(医学版), 2021, 53(6): 1196-1200. |
[2] | 刘梅歌,方朴,王严,丛璐,范洋溢,袁远,徐燕,张俊,洪道俊. 远端型遗传性运动神经病8例的临床、病理及遗传学特点[J]. 北京大学学报(医学版), 2021, 53(5): 957-963. |
[3] | 高伟波,石茂静,张海燕,吴春波,朱继红. 显著高铁蛋白血症与噬血细胞性淋巴组织细胞增多症的相互关系[J]. 北京大学学报(医学版), 2021, 53(5): 921-927. |
[4] | 张梅香,史文芝,刘建新,王春键,李燕,王蔚,江滨. MLL-AF6融合基因阳性急性髓系白血病的临床特征及预后[J]. 北京大学学报(医学版), 2021, 53(5): 915-920. |
[5] | 蒋艳芳,王健,王永健,刘佳,裴殷,刘晓鹏,敖英芳,马勇. 前交叉韧带翻修重建术后中长期临床疗效及影响因素[J]. 北京大学学报(医学版), 2021, 53(5): 857-863. |
[6] | 肖若陶,刘承,徐楚潇,何为,马潞林. 术前血小板参数与局部进展期肾细胞癌预后[J]. 北京大学学报(医学版), 2021, 53(4): 647-652. |
[7] | 于妍斐,何世明,吴宇财,熊盛炜,沈棋,李妍妍,杨风,何群,李学松. 延胡索酸水合酶缺陷型肾细胞癌的临床病理特征及预后[J]. 北京大学学报(医学版), 2021, 53(4): 640-646. |
[8] | 赵勋,颜野,黄晓娟,董靖晗,刘茁,张洪宪,刘承,马潞林. 癌栓粘连血管壁对非转移性肾细胞癌合并下腔静脉癌栓患者手术及预后的影响[J]. 北京大学学报(医学版), 2021, 53(4): 665-670. |
[9] | 陈怀安,刘硕,李秀君,王哲,张潮,李凤岐,苗文隆. 炎症生物标志物对输尿管尿路上皮癌患者预后预测的临床价值[J]. 北京大学学报(医学版), 2021, 53(2): 302-307. |
[10] | 刘世博,高辉,冯元春,李静,张彤,万利,刘燕鹰,李胜光,罗成华,张学武. 腹膜后纤维化致肾盂积水的临床分析:附17例报道[J]. 北京大学学报(医学版), 2020, 52(6): 1069-1074. |
[11] | 程功,张霞,杨菲,程嘉渝,刘燕鹰. 以发热、关节炎、皮肤色素沉着为主要表现的血管免疫母细胞性T细胞淋巴瘤1例[J]. 北京大学学报(医学版), 2020, 52(6): 1150-1152. |
[12] | 陈伟钱,戴小娜,余叶,王沁,梁钧昱,柯旖旎,易彩虹,林进. 原发性干燥综合征合并自身免疫性肝病的临床特点及预后分析[J]. 北京大学学报(医学版), 2020, 52(5): 886-891. |
[13] | 姜妮,乔国梁,王小利,周心娜,周蕾,宋雨光,赵艳杰,任军. 中性粒细胞与淋巴细胞比例对评估接受过继性细胞免疫治疗的晚期胰腺癌患者预后的临床意义[J]. 北京大学学报(医学版), 2020, 52(3): 597-602. |
[14] | 马茹,李鑫宝,闫风彩,林育林,李雁. 肿瘤间质比评估阑尾来源腹膜假黏液瘤的临床价值[J]. 北京大学学报(医学版), 2020, 52(2): 240-246. |
[15] | 王文鹏,王捷夫,胡均,王俊锋,刘嘉,孔大陆,李健. 结直肠间质瘤临床病理特征及预后分析[J]. 北京大学学报(医学版), 2020, 52(2): 353-361. |
|